ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.

AVTE Aerovate Therapeutics Inc

21,57
0,37 (1,75%)
26 Avr 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 117 966
Prix Achat 8,81
Prix Vente 34,67
Actualités -
Maximum Haut 22,13

Bas
9,41

Sur 52 semaines

Haut
32,415

Minimum Bas 19,83
Nom Action Symbole Action Marché Type
Aerovate Therapeutics Inc AVTE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
0,37 1,75% 21,57 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
20,40 19,83 22,13 21,57 21,20
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
2 831 117 966 US$ 21,06 US$ 2 484 687 - 9,41 - 32,415
Dernière Transaction Type Quantités échangées Prix transaction Devise
22:20:01 formt 484 US$ 21,57 USD

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
597,37M 27,67M - 0 -75,52M -2,73 -
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Aerovate Therapeutics

Date Heure Source Titre
27/3/202414:20GlobeNewswire Inc.Aerovate Therapeutics to Present Patient Baseline..
25/3/202421:10GlobeNewswire Inc.Aerovate Therapeutics Announces Full-Year 2023 Financial..
11/3/202423:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
07/3/202422:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
06/3/202414:00GlobeNewswire Inc.Aerovate Therapeutics Board of Directors Appoints Habib..
28/2/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
23/2/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
21/2/202400:38Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
09/2/202422:28Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
25/1/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
25/1/202400:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..

Forum Action Aerovate Therapeutics

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Aerovate Therapeutics Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine22,4423,976419,8321,88199 442-0,87-3,88%
1 mois29,0132,41519,8325,74179 408-7,44-25,65%
3 mois19,5232,41516,7424,75146 9342,0510,50%
6 mois11,0432,4159,4121,63114 98810,5395,38%
1 an19,3332,4159,4119,2797 4182,2411,59%
3 ans28,0032,4157,7418,5698 501-6,43-22,96%
5 ans28,0032,4157,7418,5698 501-6,43-22,96%

Dernières Valeurs Consultées

Delayed Upgrade Clock